AWHLOTCIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Aspira Women's Health Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.22−0.01 (-2.61%)
Close on Oct 19, 2026
- Market cap
- $9.91M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Aspira Women's Health's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 6, 2026 | Jul 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 22, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2026 | Jun 9, 2026 | SEC EDGAR |
| Current report | 8-K | May 20, 2026 | May 26, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 26, 2026 | Apr 30, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 17, 2026 | Apr 24, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Apr 1, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2026 | Jan 30, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 29, 2025 | Dec 31, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 23, 2025 | Dec 23, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2025 | Dec 22, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 14, 2025 | Oct 15, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 19, 2025 | Sep 25, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2025 | Sep 18, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2025 | Sep 3, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 11, 2025 | Jul 15, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 11, 2025 | Jun 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 19, 2025 | SEC EDGAR |
| Current report | 8-K | May 19, 2025 | May 19, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2025 | Apr 16, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 31, 2024 | Apr 11, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 2, 2025 | Apr 8, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 28, 2025 | Mar 31, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2025 | Mar 31, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2025 | Mar 27, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 21, 2025 | Mar 25, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 15, 2025 | Mar 19, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2025 | Mar 11, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2025 | Feb 14, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 5, 2025 | Feb 10, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2025 | Jan 31, 2025 | SEC EDGAR |